Next Article in Journal
Collaboration between Psychiatrists and Other Allied Medical Specialists for the Treatment of Delusional Disorders
Previous Article in Journal
“Degrees of Freedom”: Comparing Mental Distress of Populations with Different Levels of Access to Care-Prisoners, Psychiatric Patients and General Population
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Infection Route of Parvimonas micra: A Case Report and Systematic Review

1
Community Care, Unnan City Hospital, Unnan 699-1221, Japan
2
Department of Community Medicine Management, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan
*
Authors to whom correspondence should be addressed.
Healthcare 2022, 10(9), 1727; https://doi.org/10.3390/healthcare10091727
Submission received: 23 July 2022 / Revised: 30 August 2022 / Accepted: 6 September 2022 / Published: 8 September 2022

Abstract

:
Parvimonas micra (P. micra), a bacterium that colonizes the gastrointestinal tract, is often isolated from periodontitis and abscesses as part of a complex bacterial infection. However, reports of monobacterium infections due to P. micra are limited. Here, we report a case of monobacterial bacteremia caused by P. micra with the aim of identifying the source of the invasion and clarifying the clinical features. A 54-year-old patient presented with bacteremia due to P. micra and with an oral invasion that we suspected resulted from prior dental treatment. Using PubMed and Google Scholar databases, we undertook a systematic review of monobacteremia caused by P. micra. We identified 26 patients (mean age, 70.15 years) in our systematic review. P. micra bacteremia and its associated phenotypes were most frequently identified in spinal discitis, followed by epidural and lumbar abscesses, and infective endocarditis. The major risk factors were malignancy, diabetes mellitus, and post-arthroplasty. When P. micra is detected in blood cultures, evaluation and intervention for oral contamination may be indicated.

1. Introduction

Parvimonas micra (P. micra) inhabits the oral cavity and intestinal tract in humans [1]. It is an obligate anaerobe and a small (0.3–0.7 μm) Gram-positive coccus that causes various infections in immunocompromised hosts. Originally, it was identified as Peptostreptococcus micros in 1933, but was reclassified as Micrcomonas micros in 1999, and finally as P. micra in 2006 [2]. P. micra infections have increased in nosocomial and immunocompromised hosts because of aging societies [2]. Primary care healthcare workers need to be aware of these types of infections.
P. micra is a component of the oral, upper respiratory, and intestinal microflora, and is of major clinical and bacteriological importance owing to its high isolation rate within clinical material, owing to poor hygiene among immunocompromised older patients in aging societies [2]. Its pathogenic potential has been implicated in chronic periodontal disease, alveolar abscess, peritonsillar abscess, chronic sinusitis, chronic otitis media, and pulmonary pyogenic disease [3]. It is known to be involved in deep-seated infections, such as those occurring around artificial joints [3]. The pathogenicity of P. micra includes the presence of capsid, high protease activity, and hydrogen sulfide toxicity produced by the utilization of glutathione [3]. Socially isolated patients, those with a low socioeconomic status, those with poor hygiene, and immunocompromised patients are vulnerable to this infection and may be at high risk owing to the absence of habitual oral care [2,3].
P. micra is difficult to identify because of its lack of clinical symptoms and slow growth, and the need for special culture media and identification methods [4,5,6]. Pyogenic spondylitis is the most common infection caused by P. micra, and pyogenic arthritis (post-knee arthroplasty), infective endocarditis, pleurisy, meningitis, and brain abscess have been reported [7]. As P. micra is an anaerobic inhabitant of the oral microbiome, risk factors include dental procedures, periodontitis, tooth extractions, and oral infections, such as abscesses or caries on the lingual apex [7]. P. micra may be multi-drug-resistant and may co-infect with other multi-drug-resistant bacteria in relation to cephalosporins and quinolone, resulting in a polymicrobial etiology for endogenous oral infections, such as periodontitis, while also being detected in soft tissues, skin infections, and various abscesses [8,9,10,11]. P. micra co-pathogens associated with polymicrobial infections include Streptococcus, Bacteroides, and Fusobacterium [12]. In increasingly aging societies, healthcare workers encounter various symptoms in older patients, and the etiologies of their symptoms could derive from the bacteremia of P. micra. Therefore, healthcare workers should be mindful of the likelihood of P. micra infections among older adults.
It remains unknown how P. micra monoinfections are transmitted and which patient populations are affected. Clarification of the transmission of P. micra monoinfections is vital for prevention and effective treatment. When P. micra is detected in blood cultures, early diagnosis and therapeutic interventions are possible. If the most common routes of infection could be identified, along with the background of patients susceptible to P. micra bacteremia, clinicians could more accurately determine a targeted treatment pathway against the primary disease. However, clinical diagnosis of P. micra monoinfections and treatment remain challenging. Here, we present the case of a 54-year-old man with P. micra bacteremia. We aimed to identify the source of the invasion and its clinical features, to highlight challenges in diagnosis and treatment. We also aimed to investigate the transmission of P. micra monoinfections and identify the affected patient population through undertaking a systematic review of relevant case reports concerning P. micra bacteremia.

2. Materials and Methods

2.1. Case Report

A 54-year-old Japanese male visited our hospital complaining of persistent fever and headaches. The headaches were mild and pulsated from the anterior to the posterior region of his head. He had a long history of dental treatment, and all of his teeth had been replaced with dentures. He had also been experiencing pain in his mouth for three days: pain was present in his mandible whilst chewing, although there was no tenderness. He had a past medical history of hypertension and stroke and was taking antiplatelet and antihypertensive medication. He was a construction worker, lived with his elderly mother, had smoked 40 cigarettes a day for 40 years, and had no history of alcohol consumption.
The patient’s vital signs on arrival were as follows: Glasgow Coma Scale, 15 points; blood pressure, 129/94 mmHg; pulse, 121 beats/min; respiratory rate, 18 breaths/min; SpO2, 96% (room air); and body temperature, 39.4 °C. In the physical examination, no obvious physical abnormality was noted, such as nuchal rigidity, jolt accentuation, tenderness in the sinuses or in the head and neck, moist rales, obvious abdominal findings, costovertebral angle tapping pain, or arthritis. To exclude oral infection, sepsis, and abscess, blood tests, urinalysis, and a computed tomography (CT) scan were performed. The blood examination results showed an elevated white blood cell count, but no abnormalities were noted in the CT scan and urinalysis. The patient was sent home after blood cultures were taken on the same day. The blood culture test results were positive for P. micra. The patient was urged to visit the outpatient clinic, but he did not attend. In the meantime, antipyretic analgesics were prescribed, but no antibiotics. The patient attended an outpatient clinic two weeks later in good condition.

2.2. Systematic Review

2.2.1. Search Strategy

The following keywords were searched on Google Scholar and PubMed online databases: “Parvimonas micra” and “bacteremia.”

2.2.2. Inclusion and Exclusion Criteria

Studies written in Japanese and English and published after 2006 on bacteremia associated with P. micra and associated diseases, such as sepsis, abscess, and spondylitis, were included. Studies published prior to 2006, those written in languages other than Japanese or English, and those in which P. micra was detected in samples other than blood were excluded. Inclusion and exclusion criteria are summarized in Table 1.

2.2.3. Data Extraction

We used the search terms “Parvimonas micra” and “bacteremia” in Google scholar and PubMed online databases. The first and second authors read the full text and independently extracted the data. After data extraction, they discussed the extracted data, and once consensus had been reached regarding the inclusion of a study, the data were captured in an Excel file. This systematic review was registered in PROSPERO (registration number: 316707) and conducted according to standard procedures.

2.2.4. Analysis

Quantitative and qualitative data are presented as descriptive statistics. Collected data were divided into various categories.

3. Results

3.1. Search Results

In total, 45 studies met the inclusion criteria. Of these, seven studies were excluded because of duplication. After reviewing the entire texts, 15 studies were excluded for the following reasons: two studies had been written in Korean or German, and in 13 studies, the samples used for detection were not blood samples. Finally, a total of 23 studies were identified, and 26 case reports were included in the final analysis (Figure 1) [4,11,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33].

3.2. Demographics

The mean age of the patients with P. micra bacteremia was 70.15 years (age range: 41–94). Males were the predominant sex (80.8%). The most common complaints were fever (n = 13, 50%), weight loss (n = 3), malaise (n = 3), and nausea and vomiting (n = 2). In addition, back pain was the chief complaint in all eight cases of spondylodiscitis and epidural abscess. In the case of septic arthritis of the knee, tenderness of the right knee was the chief complaint.

3.3. Medical History

Of 26 patients, the underlying diseases were spondylodiscitis in seven (26.9%) patients, epidural abscess in five (19.2%) patients, psoas abscess in four (15.3%) patients, infective endocarditis in four (10.5%) patients, and malignancy in three (11.5%) patients. The most frequent comorbidity was the history of diabetes mellitus in eight (30.7%) patients, hypertension in seven (26.9%) patients, malignant tumor in three (11.5%) patients, dyslipidemia in two (7.69%) patients, and artificial joint replacement in two (7.69%) patients.

3.4. Entry/Route of Infection

There were 13 reported cases of oral infection (50%), one respiratory tract infection (3.84%), one bacterial translocation (3.84%), one mucosal infection (3.84%), and one percutaneous infection (3.84%). Nine (34.6%) patients had no recorded details regarding the route of infection.

3.5. Outcome

Following the hospitalization period, 21 of 26 (81.8%) patients survived (Table 2).

4. Discussion

We performed a systematic review to identify the route of infection of P. micra and its clinical features. Spinal discitis, followed by epidural abscess, lumbar abscess, and infective endocarditis, were most frequently associated with P. micra bacteremia. The most frequent risk factors were malignancy, followed by diabetes mellitus and post-prosthetic joint replacement. We found that oral infections due to dental treatment and dental caries were the most frequent causes, although many cases were reported to have an unknown route of infection.
No specific symptoms related to P. micra infection were observed. Fever was present in 46% of the reported cases, and other chief complaints included general malaise, impaired consciousness, and anorexia. Pain was the main complaint in all patients, which was associated with inflammation of the musculoskeletal system, such as spondylitis and arthritis. In patients with pain, an aggressive search for the source of infection, such as local abscess formation, is necessary.
It is currently unclear why the spinal region is the primary target for these infections [29]. In a case series of spondylitis due to P. micra reported by Durovic et al. [28], even a mild fever and mildly elevated inflammatory response resulted in a positive blood culture rate comparable to that detected in a CT-guided biopsy. This suggests that anaerobic infection by P. micra should be suspected even in the absence of symptoms.
All patients who presented with infective endocarditis had a history of dental procedures, such as tooth extractions. It has long been known that transient bacteremia due to dental procedures is a cause of infective endocarditis [34]. Bacteria entering the bloodstream after dental procedures, such as tooth extraction, are rapidly eliminated by the liver and other reticuloendothelial tissues, and most disappear from the bloodstream within a short period; this is referred to as transient bacteremia [35]. Sakamoto [36] reported that the frequency of bacteremia after tooth extractions was 100%, with wisdom tooth extractions accounting for 55%, and that the frequency of bacteremia after tartar removal was 70%. The frequency of bacteremia has been reported to be higher for periodontal extractions [37]. Non-dental bacteremia has been reported as being due to daily tooth brushing (30%), chewing (38%), and dental flossing [38,39,40,41,42,43,44]. Of these, the risk associated with tooth brushing has been emphasized in recent years [38,39]. The presence of bacteremia induced in the oral cavity through such routine practices has led to a strong recognition of the importance of routine oral follow-ups [39,45]. The European Society of Cardiology guidelines recommend that, as a general precaution, high- and intermediate-risk patients should undergo rigorous dental follow-ups twice a year for if they are at particularly high risk and once a year otherwise. To prevent infectious endocarditis, control of periodontal disease and caries is critical, and regular dental and oral management is crucial, even when a patient is asymptomatic.
Given P. micra forms part of the oral microflora, the main risk factors and routes of infection for P. micra bacteremia are dental treatments such as periodontitis, tooth extractions, and dental abscesses [46]. In our systematic review, 13 (50%) patients were identified as having experienced at least one of these complications. The pathogenicity of P. micra in oral infections has been attributed to factors such as adhesion to gingival epidermal cells, cell morphology proteolytic enzymes, and the macrophage response [47,48]. Most patients had received dental care prior to infection. In this study, other relevant patient histories included type 2 diabetes mellitus, colorectal cancer, pressure ulcers, and aspiration. Previous studies have reported that P. micra bacteremia is associated with aspiration pneumonia, suggesting that postoperative stress and increased dead space due to increased sputum production may have led to an increase in P. micra [16,17,19]. In addition, some cases of P. micra bacteremia possibly due to ulcers or endoscopic procedures have been reported, and trauma due to intestinal mucosal injury may predispose one to bacteremia. Nine cases had no description of the route of infection in the case presentation or discussion; these patients presented with liver abscess, splenic abscess, spinal discitis, epidural abscess, intradural abscess, and diabetes mellitus, and had no history of dental treatment.
The route of infection in one (3.84%) patient was considered to be bacterial translocation. Several factors contribute to the development of bacterial translocation. Most are abnormalities in the intestinal microbiota, disruption of the physical and immune barrier of the gut, and a reduction in systemic immunity [49]. For example, cases involving intestinal obstruction, jaundice, inflammatory bowel disease, malignancy, emergency surgery, and gastric colonization with microorganisms have been reported [50,51,52,53,54,55,56,57,58,59,60,61,62]. In our patient, malignancy may have compromised host immunity and intestinal barrier function, and the bacteria may have therefore metastasized. Therefore, it is necessary to search for immunosuppression or gastrointestinal malignancy as a possible cause of P. micra bacteremia.
Concerning treatment and antimicrobial susceptibility, in one previous study, 3.2% of patients did not respond to treatment with metronidazole [63]; however, most patients did respond to treatment with common antimicrobial agents. Although P. micra is considered to have good antimicrobial susceptibility, drug selection should be monitored through susceptibility testing [62,63]. When an abscess forms, surgical drainage is essential because antimicrobial agents rarely migrate into the abscess [52,53,54,55]. Our review showed that P. micra caused abscesses in 38.4% of patients. Drainage was performed in almost all cases involving liver abscesses, splenic abscesses, pyothorax, epidural abscesses, iliolumbar muscle abscesses, pyogenic pericarditis, infected knee arthritis, and brain abscesses, in addition to five out of seven cases involving splenic abscesses. Control of the infected site through drainage and antibiotic therapy is important in cases of abscess formation [52,53,54,55].
Regarding prognosis, one patient with in situ carcinoma became debilitated owing to the infection and ruptured an abdominal aortic aneurysm, which ultimately resulted in death [57,58,59]. Anaerobic infections by bacteria such as P. micra require early detection and treatment [53,54,55,56]. In patients who are at risk of severe disease, the threshold for searching for infections such as abscesses and infective endocarditis should be lowered for those with diabetes mellitus, non-invasive cancer, and poor oral hygiene, even in those with non-specific symptoms such as fever and malaise [60,61,62]. Abscess formation should be considered, especially when accompanied with localized pain, as P. micra is an anaerobe and tends to cause abscess formation.
Our patient was treated in the emergency room, and the details of the disease’s course remain unknown. Our patient had a history of dental treatment, oral contamination, a painful mouth, and no other febrile findings, suggesting a high probability that P. micra bacteremia occurred via the oral cavity. Our patient was an immunocompetent individual with no history of diabetes mellitus, cancer, or steroid use. Based on the clinical course, the patient had transient bacteremia caused by P. micra that resolved spontaneously. Therefore, consistent follow-up and health maintenance are needed because of the possibility of abscess formation, infective endocarditis, or spondylitis.

5. Conclusions

The spine is the most common site of underlying disease for P. micra bacteremia, followed by epidural abscesses, lumbar abscesses, infective endocarditis, and malignancy. The presumed route of entry is oral in most cases. The major risk factors are malignancy, diabetes mellitus, and post-arthroplasty. Patients with local abscess infection experience local tenderness. Therefore, at-risk patients should undergo thorough examination and treatment for suspected abscess formation, based on physical findings, such as the presence of oral contamination and local tenderness. Bacterial translocation is one possible mechanism of bacteremia caused by P. micra. A malignant tumor of the gastrointestinal tract may be the underlying cause, and the possibility of tumors should be eliminated.

Author Contributions

Conceptualization, K.S., Y.H. and R.O.; Methodology, K.S.; Software, K.S.; Validation, K.S.; Formal Analysis, K.S., Y.H. and R.O.; Investigation, Y.H., K.S. and R.O.; Resources, Y.H., K.S. and R.O.; Data Curation, Y.H. and K.S.; Writing—Original Draft Preparation, Y.H., K.S. and R.O.; Writing—Review & Editing, Y.H., K.S. and R.O.; Visualization, Y.H.; Supervision, C.S.; Project Administration, R.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Informed consent was obtained from the patient involved in the case report.

Data Availability Statement

All relevant data are presented in the manuscript.

Acknowledgments

We would like to thank all of the colleagues who collaborate in this research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Murphy, E.C.; Frick, I.M. Gram-Positive Anaerobic Cocci—Commensals and Opportunistic Pathogens. FEMS Microbiol. Rev. 2013, 37, 520–553. [Google Scholar] [CrossRef]
  2. Tindall, B.J.; Euzéby, J.P. Proposal of Parvimonas Gen. Nov. and Quatrionicoccus Gen. Nov. as Replacements for the Illegitimate, Prokaryotic, Generic Names Micromonas Murdoch and Shah 2000 and Quadricoccus Maszenan et al. 2002, Respectively. Int. J. Syst. Evol. Microbiol. 2006, 56, 2711–2713. [Google Scholar] [CrossRef]
  3. Cobo, F.; Rodríguez-Granger, J.; Sampedro, A.; Aliaga-Martínez, L.; Navarro-Marí, J.M. Pleural Effusion Due to Parvimonas micra. A Case Report and a Literature Review of 30 Cases. Rev. Esp. Quimioter. 2017, 30, 285–292. [Google Scholar]
  4. Sultan, A.A.; Cantrell, W.A.; Khlopas, A.; Cole, C.; Piuzzi, N.S.; Sodhi, N.; Brooks, P.; Mont, M.A. Acute Septic Arthritis of the Knee: A Rare Case Report of Infection with Parvimonas micra after an Intra-articular Corticosteroid Injection for Osteoarthritis. Anaerobe. 2018, 51, 17–20. [Google Scholar] [CrossRef] [PubMed]
  5. Bartz, H.; Nonnenmacher, C.B.; Bollmann, C.; Kuhl, M.; Zimmermann, S.; Heeg, K.; Mutters, R. Micromonas (Peptostreptococcus) micros: Unusual Case of Prosthetic Joint Infection Associated with Dental Procedures. Int. J. Med. Microbiol. 2005, 294, 465–470. [Google Scholar] [CrossRef]
  6. Riggio, M.P.; Lennon, A. Identification of Oral Peptostreptococcus Isolates by PCR-Restriction Fragment Length Polymorphism Analysis of 16S rRNA Genes. J. Clin. Microbiol. 2003, 41, 4475–4479. [Google Scholar] [CrossRef] [PubMed]
  7. Didilescu, A.C.; Rusu, D.; Anghel, A.; Nica, L.; Iliescu, A.; Greabu, M.; Bancescu, G.; Stratul, S.I. Investigation of Six Selected Bacterial Species in Endo-periodontal Lesions. Int. Endod. J. 2012, 45, 282–293. [Google Scholar] [CrossRef]
  8. Bowler, P.G.; Davies, B.J. The Microbiology of Infected and Noninfected Leg Ulcers. Int. J. Dermatol. 1999, 38, 573–578. [Google Scholar] [CrossRef] [PubMed]
  9. Lafaurie, G.I.; Mayorga-Fayad, I.; Torres, M.F.; Castillo, D.M.; Aya, M.R.; Barón, A.; Hurtado, P.A. Periodontopathic Microorganisms in Peripheric Blood after Scaling and Root Planing. J. Clin. Periodontol. 2007, 34, 873–879. [Google Scholar] [CrossRef] [PubMed]
  10. Murdoch, D.A.; Mitchelmore, I.J.; Tabaqchali, S. Peptostreptococcus micros in Polymicrobial Abscesses. Lancet. 1988, 1, 594. [Google Scholar] [CrossRef]
  11. Garrido-Jareño, M.; Frasquet-Artes, J.; Tasias-Pitarch, M.; López-Hontangas, J.L. First Case of Renal Abscess by Parvimonas micra. Enferm. Infecc. Microbiol. Clin. 2019, 37, 140–141. [Google Scholar] [CrossRef] [PubMed]
  12. Cesta, N.; Foroghi Biland, L.; Neri, B.; Mossa, M.; Campogiani, L.; Caldara, F.; Zordan, M.; Petruzziello, C.; Monteleone, G.; Fontana, C.; et al. Multiple Hepatic and Brain Abscesses Caused by Parvimonas micra: A Case Report and Literature Review. Anaerobe 2021, 69, 102366. [Google Scholar] [CrossRef] [PubMed]
  13. Watanabe, T.; Yokoe, M.; Noguchi, Y. Septic Pulmonary Embolism Associated with Periodontal Disease: A Case Report and Literature Review. BMC Infect. Dis. 2019, 19, 74. [Google Scholar] [CrossRef] [PubMed]
  14. Khan, M.S.; Ishaq, M.; Hinson, M.; Potugari, B.; Rehman, A.U. Parvimonas micra Bacteremia in a Patient with Colonic Carcinoma. Caspian J. Intern. Med. 2019, 10, 472–475. [Google Scholar] [CrossRef] [PubMed]
  15. Ko, J.H.; Baek, J.Y.; Kang, C.I.; Lee, W.J.; Lee, J.Y.; Cho, S.Y.; Ha, Y.E.; Kim, S.H.; Chung, D.R.; Peck, K.R.; et al. Bacteremic Meningitis Caused by Parvimonas micra in an Immunocompetent Host. Anaerobe 2015, 34, 161–163. [Google Scholar] [CrossRef]
  16. García Carretero, R.; Luna-Heredia, E.; Olid-Velilla, M.; Vazquez-Gomez, O. Bacteraemia due to Parvimonas micra, a Commensal Pathogen, in a Patient with an Oesophageal Tumour. BMJ Case Rep. 2016, 2016, bcr2016217740. [Google Scholar] [CrossRef]
  17. Boattini, M.; Bianco, G.; Cavallo, R.; Costa, C. Parvimonas micra Bacteremia Following Endoscopic Retrograde Cholangiopancreatography: A New Route of Infection. Anaerobe 2018, 54, 136–139. [Google Scholar] [CrossRef]
  18. Cobo, F.; Borrego, J.; Rojo, M.D.; Navarro-Marí, J.M. Polymicrobial Anaerobic Bacteremia Due to Atopobium rimae and Parvimonas micra in a Patient with Cancer. Anaerobe 2018, 54, 260–263. [Google Scholar] [CrossRef]
  19. Suzuki, T.; Ishikawa, K.; Matsuo, T.; Kijima, Y.; Aoyagi, H.; Kawai, F.; Komiyama, N.; Mori, N. Pacemaker Infection and Endocarditis Due to Parvimonas micra: A Case Report and Systematic Review. Anaerobe 2021, 72, 102459. [Google Scholar] [CrossRef]
  20. Gomez, C.A.; Gerber, D.A.; Zambrano, E.; Banaei, N.; Deresinski, S.; Blackburn, B.G. First Case of Infectious Endocarditis Caused by Parvimonas micra. Anaerobe 2015, 36, 53–55. [Google Scholar] [CrossRef]
  21. Ross, S.C. A Rare Case of Parvimonas micra Bacteremia. Proc. UCLA Health 2019, 23. Available online: https://proceedings.med.ucla.edu/index.php/2019/11/26/a-rare-case-of-parvimonas (accessed on 22 July 2022).
  22. Kim, E.Y.; Baek, Y.H.; Jung, D.S.; Woo, K.S. Concomitant Liver and Brain Abscesses Caused by Parvimonas micra. Korean J. Gastroenterol. 2019, 73, 230–234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Higashi, Y.; Nakamura, S.; Niimi, H.; Ueno, T.; Matsumoto, K.; Kawago, K.; Sakamaki, I.; Kitajima, I.; Yamamoto, Y. Spondylodiscitis Due to Parvimonas micra Diagnosed by the Melting Temperature Mapping Method: A Case Report. BMC Infect. Dis. 2017, 17, 584. [Google Scholar] [CrossRef] [PubMed]
  24. Pilmis, B.; Israel, J.; Le Monnier, A.; Mizrahi, A. Spondylodiscitis Due to Anaerobic Bacteria About a Case of Parvimonas micra Infection. Anaerobe 2015, 34, 156–157. [Google Scholar] [CrossRef] [PubMed]
  25. Chesdachai, S.; Eberly, A.R.; Razonable, R.R. A Tale of Two Unusual Anaerobic Bacterial Infections in an Immunocompetent Man: A Case Report and Literature Review. Anaerobe 2021, 71, 102416. [Google Scholar] [CrossRef]
  26. Hale, G.R.; Sakkal, L.A.; Galanis, T. Pylephlebitis Treated with Apixaban. Hosp. Pract. 2019, 47, 192–195. [Google Scholar] [CrossRef]
  27. Ho, D.; Ang, G.; Er, C.; Yap, S.F.; Meyyur Aravamudan, V. An Unusual Presentation of Parvimonas micra Infective Endocarditis. Cureus 2018, 10, e3447. [Google Scholar] [CrossRef]
  28. Durovic, A.; Eberhard, N.; Schären, S.; Widmer, A.F. Parvimonas micra as a Rare Cause of Spondylodiscitis—Case Series from a Single Centre. Swiss. Med. Wkly. 2020, 150, w20272. [Google Scholar] [CrossRef]
  29. Ce, P.; Ca, D.; Me, M.; Jj, S. Clostridium cadaveris Bacteremia in a Critically Ill Surgical Patient with Septic Shock after Total Abdominal Colectomy: A Case Report and Review of Literature. Glob. Drugs Therap. 2016, 2, 1–4. [Google Scholar] [CrossRef]
  30. Miyazaki, M.; Asaka, T.; Takemoto, M.; Nakano, T. Severe Sepsis Caused by Parvimonas micra Identified Using 16S Ribosomal RNA Gene Sequencing Following Patient Death. IDCases ID 2020, 19, e00687. [Google Scholar] [CrossRef]
  31. Morinaga, H.; Kato, K.; Hisagi, M.; Tanaka, H. Purulent Pericarditis-Induced Intracardiac Perforation and Infective Endocarditis Due to Parvimonas micra: A Case Report. Eur. Heart J. Case Rep. 2021, 5, ytaa528. [Google Scholar] [CrossRef] [PubMed]
  32. Sobol, G.L.; Shin, J.I.; Vives, M.J.; Dever, L.L.; Harris, C.B. Micromonas micros: A Rare Anaerobic Cause of Late Implant Failure Following Spinal Surgery. J. Spinal Cord Med. 2022, 45, 311–315. [Google Scholar] [CrossRef] [PubMed]
  33. Okell, C.C.; Elliott, S.D. Bacteremia and Oral Sepsis with Special Reference to the Etiology of Subacute Endocarditis. Lancet. 1935, 2, 869–872. [Google Scholar] [CrossRef]
  34. Hall, G.; Heimdahl, A.; Nord, C.E. Bacteremia aafter Oral Surgery and Antibiotic Prophylaxis for Endocarditis. Clin. Infect. Dis. 1999, 29, 1–8. [Google Scholar] [CrossRef]
  35. Heimdahl, A.; Hall, G.; Hedberg, M.; Sandberg, H.; Söder, P.O.; Tunér, K.; Nord, C.E. Detection and Quantitation by Lysis-Filtration of Bacteremia after Different Oral Surgical Procedures. J. Clin. Microbiol. 1990, 28, 2205–2209. [Google Scholar] [CrossRef]
  36. Sakamoto, H. Antibiotic prophylaxis for infective endocarditis due to dental bacteremia. Jpn. J. Chemother. 2019, 67, 429–437. (In Japanese) [Google Scholar]
  37. Lockhart, P.B.; Brennan, M.T.; Sasser, H.C.; Fox, P.C.; Paster, B.J.; Bahrani-Mougeot, F.K. Bacteremia Associated with Toothbrushing and Dental Extraction. Circulation 2008, 117, 3118–3125. [Google Scholar] [CrossRef]
  38. Mougeot, F.K.; Saunders, S.E.; Brennan, M.T.; Lockhart, P.B. Associations between Bacteremia from Oral Sources and Distant-Site Infections: Tooth Brushing versus Single Tooth Extraction. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015, 119, 430–435. [Google Scholar] [CrossRef]
  39. Rosa, E.A.; Rached, R.N.; Tanaka, O.; Fronza, F.; Fronza, F.; Araújo Assad, R. Preliminary Investigation of Bacteremia Incidence After Removal of the Haas Palatal Expander. Am. J. Orthod. Dentofacial Orthop. 2005, 127, 64–66. [Google Scholar] [CrossRef]
  40. Lucas, V.S.; Gafan, G.; Dewhurst, S.; Roberts, G.J. Prevalence, Intensity and Nature of Bacteraemia after Toothbrushing. J. Dent. 2008, 36, 481–487. [Google Scholar] [CrossRef]
  41. Kinane, D.F.; Riggio, M.P.; Walker, K.F.; MacKenzie, D.; Shearer, B. Bacteraemia Following Periodontal Procedures. J. Clin. Periodontol. 2005, 32, 708–713. [Google Scholar] [CrossRef] [PubMed]
  42. Forner, L.; Larsen, T.; Kilian, M.; Holmstrup, P. Incidence of Bacteremia after Chewing, Tooth Brushing and Scaling in Individuals with Periodontal Inflammation. J. Clin. Periodontol. 2006, 33, 401–407. [Google Scholar] [CrossRef] [PubMed]
  43. Lockhart, P.B.; Brennan, M.T.; Thornhill, M.; Michalowicz, B.S.; Noll, J.; Bahrani-Mougeot, F.K.; Sasser, H.C. Poor Oral Hygiene as a Risk Factor for Infective Endocarditis-Related Bacteremia. J. Am. Dent. Assoc. 2009, 140, 1238–1244. [Google Scholar] [CrossRef]
  44. Habib, G.; Lancellotti, P.; Antunes, M.J.; Bongiorni, M.G.; Casalta, J.P.; Del Zotti, F.; Dulgheru, R.; El Khoury, G.; Erba, P.A.; Iung, B.; et al. 2015 ESC Guidelines for the Management of Infective Endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J. 2015, 36, 3075–3128. [Google Scholar] [CrossRef] [PubMed]
  45. Murdoch, D.A. Gram-Positive Anaerobic Streptococci: Changes in Nomenclature, Pathogenicity, and Whole-Genome Analysis. Mod. Media. 2010, 56, 16–25. [Google Scholar]
  46. Dzink, J.L.; Gibbons, R.J.; Childs, W.C.; Socransky, S.S. The Predominant Cultivable Microbiota of Crevicular Epithelial Cells. Oral Microbiol. Immunol. 1989, 4, 1–5. [Google Scholar] [CrossRef]
  47. Tanabe, S.; Bodet, C.; Grenier, D. Peptostreptococcus micros Cell Wall Elicits a Pro-inflammatory Response in Human Macrophages. J. Endotoxin Res. 2007, 13, 219–226. [Google Scholar] [CrossRef]
  48. Fukatsu, K. Pathogenesis of Bacterial Translocation. J. Jpn Surg. Soc. 2007, 108, 137–142. [Google Scholar]
  49. MacFie, J.; Reddy, B.S.; Gatt, M.; Jain, P.K.; Sowdi, R.; Mitchell, C.J. Bacterial Translocation Studied in 927 Patients over 13 Years. Br. J. Surg. 2006, 93, 87–93. [Google Scholar] [CrossRef]
  50. Sedman, P.C.; Macfie, J.; Sagar, P.; Mitchell, C.J.; May, J.; Mancey-Jones, B.; Johnstone, D. The Prevalence of Gut Translocation in Humans. Gastroenterology 1994, 107, 643–649. [Google Scholar] [CrossRef]
  51. Sagar, P.M.; MacFie, J.; Sedman, P.; May, J.; Mancey-Jones, B.; Johnstone, D. Intestinal Obstruction Promotes Gut Translocation of Bacteria. Dis. Colon Rectum. 1995, 38, 640–644. [Google Scholar] [CrossRef] [PubMed]
  52. Deitch, E.A. Simple Intestinal Obstruction Causes Bacterial Translocation in Man. Arch. Surg. 1989, 124, 699–701. [Google Scholar] [CrossRef] [PubMed]
  53. Kabaroudis, A.; Papaziogas, B.; Koutelidakis, I.; Kyparissi-Kanellaki, M.; Kouzi-Koliakou, K.; Papaziogas, T. Disruption of the Small-Intestine Mucosal Barrier after Intestinal Occlusion: A Study with Light and Electron Microscopy. J. Invest. Surg. 2003, 16, 23–28. [Google Scholar] [CrossRef]
  54. Sakrak, O.; Akpinar, M.; Bedirli, A.; Akyurek, N.; Aritas, Y. Short and Long-Term Effects of Bacterial Translocation Due to Obstructive Jaundice on Liver Damage. Hepato-Gastroenterology 2003, 50, 1542–1546. [Google Scholar] [PubMed]
  55. Kuzu, M.A.; Kale, I.T.; Cöl, C.; Tekeli, A.; Tanik, A.; Köksoy, C. Obstructive Jaundice Promotes Bacterial Translocation in Humans. Hepato-Gastroenterology 1999, 46, 2159–2164. [Google Scholar] [PubMed]
  56. Deitch, E.A.; Sittig, K.; Li, M.; Berg, R.; Specian, R.D. Obstructive Jaundice Promotes Bacterial Translocation from the Gut. Am. J. Surg. 1990, 159, 79–84. [Google Scholar] [CrossRef]
  57. Ogata, Y.; Nishi, M.; Nakayama, H.; Kuwahara, T.; Ohnishi, Y.; Tashiro, S. Role of Bile in Intestinal Barrier Function and Its Inhibitory Effect on Bacterial Translocation in Obstructive Jaundice in Rats. J. Surg. Res. 2003, 115, 18–23. [Google Scholar] [CrossRef]
  58. Takesue, Y.; Ohge, H.; Uemura, K.; Imamura, Y.; Murakami, Y.; Yokoyama, T.; Kakehashi, M.; Sueda, T. Bacterial Translocation in Patients with Crohn’s Disease Undergoing Surgery. Dis. Colon Rectum. 2002, 45, 1665–1671. [Google Scholar] [CrossRef]
  59. Nazli, A.; Yang, P.C.; Jury, J.; Howe, K.; Watson, J.L.; Söderholm, J.D.; Sherman, P.M.; Perdue, M.H.; McKay, D.M. Epithelia under Metabolic Stress Perceive Commensal Bacteria as a Threat. Am. J. Pathol. 2004, 164, 947–957. [Google Scholar] [CrossRef]
  60. Sheen-Chen, S.M.; Chau, P.; Harris, H.W. Obstructive Jaundice Alters Kupffer Cell Function Independent of Bacterial Translocation. J. Surg. Res. 1998, 80, 205–209. [Google Scholar] [CrossRef]
  61. Holland, J.; Carey, M.; Hughes, N.; Sweeney, K.; Byrne, P.J.; Healy, M.; Ravi, N.; Reynolds, J.V. Intraoperative Splanchnic Hypoperfusion, Increased Intestinal Permeability, Down-Regulation of Monocyte Class II Major Histocompatibility Complex Expression, Exaggerated Acute Phase Response, and Sepsis. Am. J. Surg. 2005, 190, 393–400. [Google Scholar] [CrossRef] [PubMed]
  62. Sistino, J.J.; Acsell, J.R. Systemic Inflammatory Response Syndrome (SIRS) Following Emergency Cardiopulmonary Bypass: A Case Report and Literature Review. J. Extra Corpor. Technol. 1999, 31, 37–43. [Google Scholar] [PubMed]
  63. Kouzu, K.; Tsujimoto, H.; Kishi, Y.; Ueno, H.; Shinomiya, N. Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment. Biomedicines 2022, 10, 380. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Flowchart of the study selection process for the systematic review.
Figure 1. Flowchart of the study selection process for the systematic review.
Healthcare 10 01727 g001
Table 1. Inclusion and exclusion criteria.
Table 1. Inclusion and exclusion criteria.
Inclusion CriteriaExclusion Criteria
Studies published after 2006Studies published before 2006
Studies with P. micra and bacteremia in the titleGerman, Korean, and other non-English-language studies
Studies in Japanese and EnglishStudies in which P. micra was detected in samples other than blood
Table 2. Studies included in the review.
Table 2. Studies included in the review.
SourceAge (Years)SexChief ComplaintUnderlying CauseMedical HistoryOrganism(s)Antibiotic TreatmentDrainageOutcomeInfection Route
[11]65MaleFever, chill, weight loss, abdominal painRenal abscessRenal cystP. micraMEPN, VCM→ETP,
CLDM
-SurvivalDental treatment→oral infection
[12]72FemaleFever, general malaise, dyspneaLiver abscess, brain abscessColorectal cancer, psoriasis, hypertensionP. micraCPFX, MNZ→MEPN+SurvivalUnknown
[13]85MaleFever, general malaiseSeptic pulmonary embolismDiabetes mellitusP. micraMEPN, VCM→ABPC/SBT-SurvivalPeriodontitis/oral infection
[14]94MaleFever, constipationColorectal cancerDyslipidemia, diabetes, hypertensionP. micra
Gemella morbillorum
CTRX→ ABPC/SBT+SurvivalUnknown
[15]61MaleFever, headacheBacteremia meningitisChronic hepatitis B, dyslipidemiaP. micraCTRX, VCM→ABPC/SBT, MNZ-SurvivalDental treatment/oral infection
[16]53MaleFever, general malaise, chillsEsophageal cancerChronic alcoholic liver diseaseP. micraMEPN-Septicemia
Death (6 week)
Periodontal disease
/oral infection
[17]85MaleFever, chillsBile duct lithiasisHypertensionP. micraCPFX, PCG-SurvivalEndoscopic procedures/mucosal infection
[18]43FemaleFever,
abdominal pain, vomiting
Retroperitoneal
leiomyosarcoma
NoneAtopobium rimae
P. micra
LVFX→TAZ/PIP, MNZ-Septicemia
Death (20 days later)
Retroperitoneal tumor necrosis/unknown
[19]82MaleFever, dizzinessInfectious endocarditis pacemaker infectionSinusoidal failure syndrome, hypertension, abdominal aortic aneurysmP. micraCTRX→ABPC→GM-SurvivalDental caries/oral infection
[20]71MaleFever, chills, coughInfectious endocarditisDiabetes mellitusP. micraCTRX, VCM→PCG-SurvivalDental treatment/oral infection
[21]72MaleAbdominal pain, night sweats, feverintrahepatic portal vein thrombosisHypertensionP. micraLVFX→TAZ/PIP→CPFX, MNZ-SurvivalDental treatment/oral infection
[22]65FemaleLoss of appetite, nausea, weaknessLiver abscess, brain abscessNoneP. micraCTX, MNZ+survivalpressure ulcer/transdermal infection
[23]67MaleAbdominal painSpondylodiscitisDiabetes mellitusP. micraABPC/SBT→ABPC-SurvivalPeriodontal disease, dental treatment/oral infection
[24]83MaleLumbagoSpondylodiscitis, epidural abscess, psoas abscessLeft hip joint replacement, right knee joint replacement, ischemic heart diseaseP. micraABPC, GM→CLDM, REP-SurvivalUnknown
[25]83MaleLumbagoEpidural abscessAortic regurgitation, Atrial fibrillationDesulfovibro fairfieldensis
P. micra
ETP→PCG+SurvivalBacterial translocation
[26]77MaleFever, abdominal pain, left shoulder pain, shortness of breath, weight lossSplenic vein thrombosis, splenic abscessJejunal perforationP. micraTAZ/PIP, VCM→ABPC/SBT→ABPC+SurvivalUnknown
[27]42MaleFever, chills, coughInfectious endocarditisMVR, diabetes mellitusP. micraCTX, VCM-SurvivalDental treatment/oral infection
[28]82MaleBack pain, shoulder painSpondylodiscitis, psoas abscess, epidural abscessRenal failure, gout, lumbar discectomyP. micraABPC, MEPM+AAA rupture
death
Periodontal disease/oral infection
[28]72MaleLumbagoSpondylodiscitis,
epidural abscess
Parkinson diseaseP. micraABPC/CVA+SurvivalDental treatment/oral infection
[28]72MaleLumbagoDegenerative changes L4/5Diabetes mellitusP. micraPCG, ETP→CLDM-SurvivalUnknown
[28]72FemaleLumbagoSpondylodiscitis, epidural abscessMetastatic breast cancerP. micraABPC/CVA→MFLX+SurvivalUnknown
[4]73MalePain in right kneeSeptic arthritis of the knee, pseudogoutHypertension, diabetes mellitus, total hip replacementStaphylococcus aureus
P. micra
VCM→PCG+Survival
[29]41FemaleAbdominal pain, tachycardia, low blood pressureUlcerative colitis, pulmonary embolismUlcerative colitis, deep vein thrombosisClostridium cadaveris,
P. micra
TAZ/PIP→LZD, MNZ, MEPN, FCZ-Septicemia
Death (55 days later)
[30]83MaleLumbagoSpondylodiscitis, psoas abscess, necrotizing fasciitisProstate cancer, diabetes mellitus, hypertension, hyperuricemia, lumbar compression fractureP. micraMEPN, CLDM+Septicemia
Death (3 days later)
Diabetes, prostate cancer/unknown
[31]70MaleChest painInfectious endocarditisNoneP. micraABPC/SBT+SurvivalDental caries/oral infection
[32]59MaleLumbagoSpondylodiscitisLumbar discectomyP. micraETP→ABPC+SurvivalPeriodontal disease/oral infection
Abbreviations: ABPC, ampicillin; ABPC/SBT, sulbactam/ampicillin; AMPC/CVA, clavulanic acid/amoxicillin; CLDM, clindamycin; CPFX, ciprofloxacin; CTRX, ceftriaxone; CTX, cefotaxime; ETP, ertapenem; FCZ, fluconazole; GM, gentamicin; LVFX, levofloxacin; LZD, linezolid; MEPN, meropenem; MNZ, metronidazole; PCG, penicillin G; TAZ/PIPC, tazobactam/piperacillin; REP, rifampicin; VCM, vancomycin.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shimizu, K.; Horinishi, Y.; Sano, C.; Ohta, R. Infection Route of Parvimonas micra: A Case Report and Systematic Review. Healthcare 2022, 10, 1727. https://doi.org/10.3390/healthcare10091727

AMA Style

Shimizu K, Horinishi Y, Sano C, Ohta R. Infection Route of Parvimonas micra: A Case Report and Systematic Review. Healthcare. 2022; 10(9):1727. https://doi.org/10.3390/healthcare10091727

Chicago/Turabian Style

Shimizu, Kai, Yuta Horinishi, Chiaki Sano, and Ryuichi Ohta. 2022. "Infection Route of Parvimonas micra: A Case Report and Systematic Review" Healthcare 10, no. 9: 1727. https://doi.org/10.3390/healthcare10091727

APA Style

Shimizu, K., Horinishi, Y., Sano, C., & Ohta, R. (2022). Infection Route of Parvimonas micra: A Case Report and Systematic Review. Healthcare, 10(9), 1727. https://doi.org/10.3390/healthcare10091727

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop